A Prenuvo whole body MRI scan costs $999-4,499 depending on the package and location. The company has surpassed 110,000 members, generated $100 million in revenue in 2024, and just raised $120 million in fresh funding. Kim Kardashian called it a “lifesaving machine” in an Instagram post that received 3.4 million likes. However, the American College of Radiology does not recommend whole-body screening MRI for average-risk, asymptomatic adults. Furthermore, Fred Hutch Cancer Center says their radiologists won’t provide official reinterpretations of Prenuvo scans. The technology is genuinely impressive. The debate about whether you should actually get one is genuinely unresolved.
Prenuvo Scan Pricing Breakdown
Prenuvo offers four scan tiers. The Torso scan costs $999 and takes approximately 25 minutes. It covers major torso organs but excludes the spine. Furthermore, it’s designed for those primarily concerned about detecting cancer early.
The Head and Torso scan runs $1,799 and takes roughly 45 minutes. It adds brain imaging and includes body composition analysis. Moreover, the Comprehensive Whole Body scan costs $2,499 and evaluates major organs, brain, spine, and blood vessels in under an hour. This is the flagship product.
The Enhanced Screening packages start at $3,999 in most markets and $4,499 in New York City. This tier adds lab testing for blood biomarkers, an advanced Brain Health Assessment, and FDA-cleared Body Composition Analysis. Additionally, the neurological scan uses specialized sequences to assess blood flow and brain microvascular structure.
What the Scan Actually Detects
Prenuvo claims its technology can detect over 500 conditions across 33 organs. These include solid tumors (often at Stage 1), aneurysms, multiple sclerosis, and hundreds of other conditions. The scans use no radiation and no contrast dye. Furthermore, they take under an hour. Every scan is reviewed by board-certified radiologists from a team of over 150 medical professionals.
However, significant limitations exist. The scans do not evaluate the heart or heart vessels. They do not assess detailed lung microarchitecture. Furthermore, they do not replace mammograms, colonoscopies, or dedicated breast imaging. The breast portion specifically lacks the intravenous contrast required by the American College of Radiology for accreditation. Additionally, the scans have limited ability to detect lesions in mucosal tissue throughout the gastrointestinal tract.
The False Positive Problem
A 2019 systematic review estimated a pooled false-positive rate of approximately 16% for whole-body MRI screening in asymptomatic people. That means roughly one in six healthy people will receive concerning findings that require follow-up testing. Furthermore, nearly everyone has some imaging abnormalities. Spine degeneration appears in almost every scan. Benign lesions are common.
These incidental findings trigger additional imaging, specialist visits, biopsies, and procedures. Consequently, the downstream cost can significantly exceed the scan itself. Prenuvo addresses this by documenting findings at a healthy baseline for future comparison. Nevertheless, the anxiety and expense of follow-up testing remains a legitimate concern.
The Business: $100 Million and Growing
Prenuvo’s growth has been explosive. The company generated $100 million in revenue in 2024. Furthermore, it operates 17 clinics across North America with plans for 15 additional locations including sites in Europe and Australia. The February 2025 funding round of $120 million was co-led by Left Lane Capital, Forerunner Ventures, and existing investor Felicis.
CEO Andrew Lacy stated the company is profitable. Additionally, Prenuvo claims the largest repository of whole-body MRI imaging in the world. This data advantage positions the company to build AI models for more accurate and efficient screening. Competitor Ezra raised $21 million in a separate round. The full-body MRI screening market is consolidating around major players.
Medical Community Response
The medical establishment remains divided. The ACR does not recommend whole-body screening MRI for average-risk, asymptomatic adults. Specifically, they cite lack of evidence for life extension, cost-effectiveness concerns, and risks from incidental findings. Furthermore, the FDA does not recommend full-body scans for healthy people.
Fred Hutch Cancer Center and UW Medicine do not offer whole-body screening and will not reinterpret Prenuvo scans. However, some radiologists argue that medical imaging has evolved dramatically. Daniel Sodickson of NYU stated that whole-body MRIs can make a real difference for preventive health when performed and interpreted correctly. The debate reflects a broader tension between innovation and evidence-based medicine.
Where Prenuvo Fits in the Longevity Economy
Prenuvo represents the consumer-facing edge of the longevity economy. It democratizes advanced imaging that was previously available only through expensive executive physical programs. At $2,499 for a comprehensive scan, it’s significantly cheaper than the $5,000-25,000 charged by the Cleveland Clinic or Mayo Clinic for similar imaging within their executive packages.
For related coverage, see concierge medicine pricing and Blueprint Protocol costs.
Take Your Next Step
Feature Article Ideas/Advertising/Brand Partnership Inquiries: Contact Social Life Magazine
Polo Hamptons Tickets, Cabanas, Brand Sponsorships: Visit Polo Hamptons
Join Our Email List: Subscribe Here
Social Life Magazine Print Subscription: Subscribe Today
Support Our Publication: Donate $5 to Social Life Magazine
Frequently Asked Questions
How much does a Prenuvo scan cost?
Prenuvo scans range from $999 to $4,499. The Torso scan costs $999. Head and Torso runs $1,799. Comprehensive Whole Body is $2,499. Furthermore, the Enhanced Screening with Whole Body costs $3,999 ($4,499 in NYC). Insurance typically does not cover these scans. HSA and FSA accounts are eligible.
Does insurance cover Prenuvo scans?
Generally no. Whole-body screening MRI is not covered by most insurance plans. However, some members have obtained full or partial reimbursement. Furthermore, Prenuvo scans qualify for HSA and FSA payment. The company recommends checking with your insurance provider to confirm any potential coverage.
Is a Prenuvo scan worth it?
It depends on risk factors. The scan can detect Stage 1 cancers and aneurysms before symptoms appear. Some patients credit early detection with saving their lives. However, the ACR does not recommend it for average-risk adults. Furthermore, a 16% false-positive rate means follow-up testing is common. Consult your physician.
How many locations does Prenuvo have?
Prenuvo operates 17 clinics across North America as of early 2025. The company plans to open 15 additional locations including sites in Europe and Australia. Furthermore, Prenuvo has surpassed 110,000 members. The company generated $100 million in revenue in 2024 and raised $120 million in funding.
What are the limitations of a Prenuvo scan?
Prenuvo scans do not evaluate the heart, heart vessels, or detailed lung microarchitecture. They do not replace mammograms, colonoscopies, or dedicated breast MRI. Furthermore, they have limited ability to detect mucosal lesions in the GI tract. A 16% false-positive rate and incidental findings are common concerns.